A phase I clinical trial of a multi-epitope polypeptide TAB9 combined with Montanide ISA 720 adjuvant in non-HIV-1 infected human volunteers

Author: Toledo H.   Baly A.   Castro O.   Resik S.   Laferte J.   Rolo F.   Navea L.   Lobaina L.   Cruz O.   Mguez J.   Serrano T.   Sierra B.   Perez L.   Ricardo M.E.   Dubed M.   Lubian A.L.   Blanco M.   Millan J.C.   Ortega A.   Iglesias E.   Penton E.   Martn Z.   Perez J.   Daz M.   Duarte C.A.  

Publisher: Elsevier

ISSN: 0264-410X

Source: Vaccine, Vol.19, Iss.30, 2001-07, pp. : 4328-4336

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content